| Financial Year |
March 31 2023 |
| Monetary Funds |
168,133,627.45 |
| Held-for-trading Financial Assets |
475,694,981.09 |
| Notes Receivable |
142,171,395.65 |
| Accounts Receivable |
324,422,360.92 |
| Advances to Suppliers |
29,537,594.06 |
| Other Receivables |
1,783,569.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,911,063.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,918,220.89 |
| Total Current Assets |
1,378,547,817.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
175,854,225.62 |
| Under-construction Projects |
3,159,881.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,001,124.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
631,845.48 |
| Deferred Income Tax Assets |
9,988,399.44 |
| Other Non-Current Assets |
11,249,808.72 |
| Sub-Total of Non-Current Assets |
220,499,734.82 |
| Total Assets |
1,599,047,552.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
148,307,356.99 |
| Accounts Payable |
224,851,490.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,293,135.64 |
| Taxes Payable |
12,463,298.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,007,261.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
276,593.21 |
| Other Current Liabilities |
148,789.43 |
| Sub-Total of Current Liabilities |
398,612,486.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,123,090.85 |
| Total Liabilities |
422,735,577.54 |
| Paid-In Capital(Or Share Stock) |
184,184,000.00 |
| Capital Surplus |
527,433,929.86 |
| Surplus Reserve |
49,003,867.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
415,690,177.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,176,311,974.95 |
| Owner's Equity（Stockholder's Equity） |
1,176,311,974.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,599,047,552.49 |
